A recent study, “Oncology Clinical Trials: Drug Development and Case Studies” examined the average number of patients per site during different phases of oncology trials. The study found that Phase 1 trials averaged 12.9 patients per site, while Phase 2 and Phase...
The Clinical Trials Transformation Initiative (CTTI), a public-private organization created to improve the way clinical trials are conducted, established the Patient Leadership Council (PLC) to involve patient advocates in its objective. The 16 member council composed...
Today, the IEDC released the below press release: INDIANAPOLIS (Jan. 29, 2013) – Pearl IRB, LLC d/b/a Pearl Pathways, a life sciences product development and regulatory consultant company, announced plans today to expand its operations here, creating up to 38 new jobs...
In a recent article by Outsourcing-Pharma, Harvard Medical School scientists from Beth Israel Deaconess Medical Center (BIDMC) claim to have identified genetic differences between people who respond to placebos during trials and those who do not. Only 122 of the 262...
The Coalition For Accelerating Standards and Therapies (CFAST) was introduced at the CDISC International Interchange in Baltimore October 22-26. By congregating experts from each industry, data standards are expected to be maintained and developed. The coalition...
